A roadmap for multi-omics data integration using deep learning

M Kang, E Ko, TB Mersha - Briefings in Bioinformatics, 2022 - academic.oup.com
High-throughput next-generation sequencing now makes it possible to generate a vast
amount of multi-omics data for various applications. These data have revolutionized …

[HTML][HTML] The role of vitamin D in breast cancer risk and progression

J Vanhevel, L Verlinden, S Doms… - Endocrine-related …, 2022 - erc.bioscientifica.com
The active form of vitamin D 3, 1, 25-dihydroxyvitamin D 3 (1, 25 (OH) 2 D 3), is primarily
known as a key regulator of calcium and phosphate homeostasis. It exerts its biological …

[HTML][HTML] Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials

HN Girithar, A Staats Pires, SB Ahn… - British Journal of …, 2023 - nature.com
Breast cancer (BrCa) is the leading cause of cancer incidence and mortality in women
worldwide. While BrCa treatment has been shown to be highly successful if detected at an …

[HTML][HTML] Antibody-drug conjugates for the treatment of HER2-positive breast cancer

MK Najjar, SG Manore, AT Regua, HW Lo - Genes, 2022 - mdpi.com
Human epidermal growth factor receptor 2 (HER2) receptor tyrosine kinase is
overexpressed in 20–30% of breast cancers and is associated with poor prognosis and …

[HTML][HTML] Survival analysis in breast cancer using proteomic data from four independent datasets

Á Ősz, A Lánczky, B Győrffy - Scientific reports, 2021 - nature.com
Breast cancer clinical treatment selection is based on the immunohistochemical
determination of four protein biomarkers: ESR1, PGR, HER2, and MKI67. Our aim was to …

[HTML][HTML] Targeted therapy and mechanisms of drug resistance in breast cancer

B Kinnel, SK Singh, G Oprea-Ilies, R Singh - Cancers, 2023 - mdpi.com
Simple Summary Internationally, in women, breast cancer (BC) is the most common cancer
type and is the leading cause of cancer-related death. There are two main histological …

[HTML][HTML] Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence—A Systematic Review

L Bouz Mkabaah, MG Davey, JC Lennon… - International Journal of …, 2023 - mdpi.com
Identifying patients likely to develop breast cancer recurrence remains a challenge. Thus,
the discovery of biomarkers capable of diagnosing recurrence is of the utmost importance …

[HTML][HTML] Notch signaling in breast tumor microenvironment as mediator of drug resistance

A Chimento, M D'Amico, V Pezzi… - International Journal of …, 2022 - mdpi.com
Notch signaling dysregulation encourages breast cancer progression through different
mechanisms such as stem cell maintenance, cell proliferation and migration/invasion …

[HTML][HTML] Estrogen receptors-mediated apoptosis in hormone-dependent cancers

A Chimento, A De Luca, P Avena, F De Amicis… - International journal of …, 2022 - mdpi.com
It is known that estrogen stimulates growth and inhibits apoptosis through estrogen receptor
(ER)-mediated mechanisms in many cancer cell types. Interestingly, there is strong evidence …

[HTML][HTML] Cannabinoids in breast cancer: differential susceptibility according to subtype

CF Almeida, N Teixeira, G Correia-da-Silva, C Amaral - Molecules, 2021 - mdpi.com
Although cannabinoids have been used for centuries for diverse pathological conditions,
recently, their clinical interest and application have emerged due to their diverse …